Title:
ALGINATE LIQUID FORMULATION
Document Type and Number:
WIPO Patent Application WO/2018/164128
Kind Code:
A1
Abstract:
Provided is a sterile alginate aqueous solution preparation which includes: (a) a monovalent metal salt of a low endotoxin alginate having a weight average molecular weight measured by a GPC-MALS method of 50000-400000; (b) a salt selected from among monovalent metal salts and ammonium salts; and (c) water. The concentration of component (a) is 1.5 mass% or higher. The concentration of component (b) is 0.5-2 mass%. The viscosity measured at 20˚C using a rotational viscometer is 2700 mPa∙s or higher. The alginate aqueous solution preparation is loaded in a sealed container or an air-tight container, is (ready-to-use) capable of being used immediately, and exhibits storage stability. Also provided is a production method for the alginate aqueous solution preparation. The alginate aqueous solution preparation is an aqueous solution preparation of a monovalent metal salt of a low endotoxin alginate and is (ready-to-use) capable of being used immediately.
Inventors:
ENDO SHUICHI (JP)
NAKAHARA MOTOI (JP)
NAKAHARA MOTOI (JP)
Application Number:
PCT/JP2018/008592
Publication Date:
September 13, 2018
Filing Date:
March 06, 2018
Export Citation:
Assignee:
MOCHIDA PHARM CO LTD (JP)
International Classes:
A61K31/734; A61K9/08; A61K47/02; A61K47/04; A61P19/00
Domestic Patent References:
WO2009054181A1 | 2009-04-30 | |||
WO2008102855A1 | 2008-08-28 | |||
WO2016114355A1 | 2016-07-21 | |||
WO2014192807A1 | 2014-12-04 | |||
WO2017163603A1 | 2017-09-28 | |||
WO2017043485A1 | 2017-03-16 | |||
WO2008102855A1 | 2008-08-28 | |||
WO1993013136A1 | 1993-07-08 |
Foreign References:
JP2010090052A | 2010-04-22 | |||
JP2016187328A | 2016-11-04 | |||
US20150250165A1 | 2015-09-10 | |||
JPS63132833A | 1988-06-04 | |||
JPH02172913A | 1990-07-04 | |||
JPH115743A | 1999-01-12 | |||
JP2011503047A | 2011-01-27 | |||
JP5684575B2 | 2015-03-11 | |||
US20150352144A1 | 2015-12-10 | |||
JP2010514707A | 2010-05-06 | |||
US8927524B2 | 2015-01-06 | |||
JPH09324001A | 1997-12-16 | |||
JPH08269102A | 1996-10-15 | |||
JP2002530440A | 2002-09-17 | |||
US5589591A | 1996-12-31 | |||
JP2005036036A | 2005-02-10 |
Other References:
KAGAKU KOGYO MAGAZINE, vol. 61, no. 7, 1958, pages 874 - 877
MURORAN INSTITUTE OF TECHNOLOGY RESEARCH REPORT, vol. 2, no. 3, 1957, pages 609 - 616
MURORAN INSTITUTE OF TECHNOLOGY RESEARCH REPORT, vol. 3, 1960, pages 443 - 449
BIOMATERIALS, vol. 6, 1985, pages 68 - 69
CHIKAKO YOMOTA, BULL. NATL. HEALTH SCI., vol. 117, 1999, pages 135 - 139
CHIKAKO YOMOTA, BULL. NATL. INST. HEALTH SCI., vol. 121, 2003, pages 30 - 33
APPL MICROBIOL BIOTECHNOL, vol. 41, 1994, pages 638 - 643
See also references of EP 3593807A4
MURORAN INSTITUTE OF TECHNOLOGY RESEARCH REPORT, vol. 2, no. 3, 1957, pages 609 - 616
MURORAN INSTITUTE OF TECHNOLOGY RESEARCH REPORT, vol. 3, 1960, pages 443 - 449
BIOMATERIALS, vol. 6, 1985, pages 68 - 69
CHIKAKO YOMOTA, BULL. NATL. HEALTH SCI., vol. 117, 1999, pages 135 - 139
CHIKAKO YOMOTA, BULL. NATL. INST. HEALTH SCI., vol. 121, 2003, pages 30 - 33
APPL MICROBIOL BIOTECHNOL, vol. 41, 1994, pages 638 - 643
See also references of EP 3593807A4
Attorney, Agent or Firm:
TANAKA Shinichiro et al. (JP)
Download PDF: